MASAC Document #161
MASAC RESOLUTION ON STEM CELL RESEARCH FOR POTENTIAL CURE OF BLEEDING DISORDERS
View Printer-Friendly PDF Version >>
The following recommendations were approved by the Medical and Scientific Advisory Council (MASAC) of the National Hemophilia Foundation on April 8, 2005, and adopted by the NHF Board of Directors on June 4, 2005
Embryonic and adult stem cell research offers the potential to cure hemophi1ia and other bleeding disorders and their complications.
The Medical and Scientific Advisory Council (MASAC) of the National Hemophilia Foundation unanimously supports embryonic and adult stem cell research as a legitimate and important area of scientific investigation and as a vital avenue of research toward curing hemophilia and other bleeding disorders. MASAC supports the application of appropriate standards to safeguard individual rights and minimize potential for abuse of this important resource.
This material is provided for your general information only. NHF does not give medical advice or engage in the practice of medicine. NHF under no circumstances recommends particular treatment for specific individuals and in all cases recommends that you consult your physician or local treatment center before pursuing any course of treatment.
Copyright 2003 National Hemophilia Foundation. To facilitate the dissemination of these medical recommendations, reproduction of any material in this publication in whole or in part will be permitted provided: 1) a specific reference to the MASAC recommendation number and title is included and 2) the reproduction is not intended for use in connection with the marketing, sale or promotion of any product or service. NHF reserves the right to make the final determination of compliance with this policy. For questions or to obtain a copy of the most recent recommendations, please contact the NHF Director of Communications at 1-800-42-HANDI or visit the NHF website at www.hemophilia.org.